v3.26.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 67,928 $ 226,016
Receivables, net of allowance for doubtful accounts 111,826 112,356
Inventories:    
Finished goods 19,535 23,087
Work in process 31,924 29,244
Raw materials 114,968 99,604
Total inventories 166,427 151,935
Prepaid expenses and other current assets 21,719 16,770
Total current assets 367,900 507,077
Property, plant and equipment, at cost 256,807 248,450
Less accumulated depreciation (173,334) (168,814)
Net property, plant and equipment 83,473 79,636
Intangible assets, at cost less accumulated amortization 157,513 118,496
Other assets 17,847 18,653
Deferred income taxes 14,110 14,140
Goodwill 302,805 235,575
Total assets 943,648 973,577
Current liabilities:    
Payables 70,275 72,299
Accrued compensation and employee benefits 21,904 37,619
Warranty and after-sale costs, current 9,761 8,466
Other current liabilities 46,356 32,332
Total current liabilities 148,296 150,716
Long-term deferred revenue 79,705 72,771
Deferred income taxes 16,616 3,477
Accrued non-pension postretirement benefits 2,435 2,499
Other accrued employee benefits 6,908 6,658
Warranty and after-sale costs, long-term 15,733 13,108
Other long-term liabilities 22,823 11,054
Commitments and contingencies (Note 5)
Total long-term liabilities 144,220 109,567
Shareholders’ equity:    
Common stock, $1 par, authorized 80,000,000, issued 37,221,098 shares in 2026 and 2025 37,221 37,221
Capital in excess of par value 82,601 75,290
Reinvested earnings 702,903 645,876
Accumulated other comprehensive income (loss) (1,662) 6,474
Less: Treasury stock, at cost, 8,657,446 shares in 2026 and 7,834,360 in 2025 (169,931) (51,567)
Total shareholders’ equity 651,132 713,294
Total liabilities and shareholders’ equity $ 943,648 $ 973,577